DHR vs OCUL · P/E 39, rev $6.26B vs rev $24.3M
Danaher Corporation (DHR) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the DHR and OCUL stock pages for the full models.
Not investment advice.